KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Merck (MRK) EBT Margin (2016 - 2025)

Merck (MRK) has disclosed EBT Margin for 17 consecutive years, with 20.85% as the latest value for Q4 2025.

  • On a quarterly basis, EBT Margin fell 584.0% to 20.85% in Q4 2025 year-over-year; TTM through Dec 2025 was 32.41%, a 134.0% increase, with the full-year FY2025 number at 32.41%, up 134.0% from a year prior.
  • EBT Margin was 20.85% for Q4 2025 at Merck, down from 39.04% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 40.03% in Q3 2021 to a low of 35.25% in Q2 2023.
  • A 5-year average of 24.4% and a median of 28.51% in 2021 define the central range for EBT Margin.
  • Peak YoY movement for EBT Margin: tumbled -6600bps in 2023, then skyrocketed 7253bps in 2024.
  • Merck's EBT Margin stood at 28.91% in 2021, then dropped by -12bps to 25.4% in 2022, then tumbled by -155bps to 13.98% in 2023, then surged by 291bps to 26.69% in 2024, then fell by -22bps to 20.85% in 2025.
  • Per Business Quant, the three most recent readings for MRK's EBT Margin are 20.85% (Q4 2025), 39.04% (Q3 2025), and 31.63% (Q2 2025).